IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys
Keywords: پروتئین ها را تکمیل کنید; VEGF; Complement proteins; Bispecific; Binding affinity; Pharmacokinetics; ACP; alternative complement pathway; AMD; age-related macular degeneration; AUC; areas under the curve; CCK-8; Cell Counting Kit-8; CCP; classical complement pathway; CL; clearance